![](/img/cover-not-exists.png)
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea
James Q. Del Rosso, Guy F. Webster, Mark Jackson, Marta Rendon, Phoebe Rich, Helen Torok, Mark BradshawVolume:
56
Year:
2007
Language:
english
DOI:
10.1016/j.jaad.2006.11.021
File:
PDF, 616 KB
english, 2007